177 related articles for article (PubMed ID: 29117780)
21. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects.
Blanche PF; Holt A; Scheike T
Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026
[TBL] [Abstract][Full Text] [Related]
22. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
[TBL] [Abstract][Full Text] [Related]
23. A causal framework for classical statistical estimands in failure-time settings with competing events.
Young JG; Stensrud MJ; Tchetgen Tchetgen EJ; Hernán MA
Stat Med; 2020 Apr; 39(8):1199-1236. PubMed ID: 31985089
[TBL] [Abstract][Full Text] [Related]
24. Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models.
Keogh RH; Gran JM; Seaman SR; Davies G; Vansteelandt S
Stat Med; 2023 Jun; 42(13):2191-2225. PubMed ID: 37086186
[TBL] [Abstract][Full Text] [Related]
25. A causal inference approach to compare leukaemia treatment outcome in the absence of randomization and with dependent censoring.
Bernasconi DP; Antolini L; Rossi E; Blanco-Lopez JG; Galimberti S; Andersen PK; Valsecchi MG
Int J Epidemiol; 2022 Feb; 51(1):314-323. PubMed ID: 34368848
[TBL] [Abstract][Full Text] [Related]
26. An inverse probability weighted regression method that accounts for right-censoring for causal inference with multiple treatments and a binary outcome.
Yu Y; Zhang M; Mukherjee B
Stat Med; 2023 Sep; 42(20):3699-3715. PubMed ID: 37392070
[TBL] [Abstract][Full Text] [Related]
27. Assessing efficacy in non-inferiority trials with non-adherence to interventions: Are intention-to-treat and per-protocol analyses fit for purpose?
Dodd M; Carpenter J; Thompson JA; Williamson E; Fielding K; Elbourne D
Stat Med; 2024 May; 43(12):2314-2331. PubMed ID: 38561927
[TBL] [Abstract][Full Text] [Related]
28. Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting.
Prats-Uribe A; Kolovos S; Berencsi K; Carr A; Judge A; Silman A; Arden N; Petersen I; Douglas IJ; Wilkinson JM; Murray D; Valderas JM; Beard DJ; Lamb SE; Ali MS; Pinedo-Villanueva R; Strauss VY; Prieto-Alhambra D
Health Technol Assess; 2021 Nov; 25(66):1-126. PubMed ID: 34812138
[TBL] [Abstract][Full Text] [Related]
29. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001911. PubMed ID: 28240353
[TBL] [Abstract][Full Text] [Related]
30. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?
Latimer NR; White IR; Abrams KR; Siebert U
Stat Methods Med Res; 2019 Aug; 28(8):2475-2493. PubMed ID: 29940824
[TBL] [Abstract][Full Text] [Related]
31. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
Howe CJ; Cole SR; Chmiel JS; Muñoz A
Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
[TBL] [Abstract][Full Text] [Related]
32. Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.
Latimer NR; Abrams KR; Lambert PC; Morden JP; Crowther MJ
Stat Methods Med Res; 2018 Mar; 27(3):765-784. PubMed ID: 27114326
[TBL] [Abstract][Full Text] [Related]
33. Causal Methods for Observational Research: A Primer.
Almasi-Hashiani A; Nedjat S; Mansournia MA
Arch Iran Med; 2018 Apr; 21(4):164-169. PubMed ID: 29693407
[TBL] [Abstract][Full Text] [Related]
34. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nolan SJ; Marson AG; Weston J; Tudur Smith C
Cochrane Database Syst Rev; 2015 Aug; (8):CD001911. PubMed ID: 26275105
[TBL] [Abstract][Full Text] [Related]
35. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
36. Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.
Nevitt SJ; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD002217. PubMed ID: 31425629
[TBL] [Abstract][Full Text] [Related]
37. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
Odondi L; McNamee R
Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
[TBL] [Abstract][Full Text] [Related]
38. Dealing with time-dependent exposures and confounding when defining and estimating attributable fractions-Revisiting estimands and estimators.
Steen J; Morzywołek P; Van Biesen W; Decruyenaere J; Vansteelandt S
Stat Med; 2024 Feb; 43(5):912-934. PubMed ID: 38122818
[TBL] [Abstract][Full Text] [Related]
39. Statistical considerations in the design and analysis of non-inferiority trials with binary endpoints in the presence of non-adherence: a simulation study.
Mo Y; Lim C; Mukaka M; Cooper BS
Wellcome Open Res; 2019; 4():207. PubMed ID: 32420455
[TBL] [Abstract][Full Text] [Related]
40. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
